You're a plant geneticist, and you want to extend the range of the world's most important human food crop, rice (Oryza sativa) into cooler regions of the world. [ + ]

A clinical trials program for neuroscience is being established as a platform by the National Neuroscience Facility (NNF) to encourage greater involvement of Australian neuroscience researchers and clinicians in industry-sponsored and investigator driven clinical studies. [ + ]

Capitalising on the successful release of its innovative Pap smear diagnostic into the European market, Polartechnics has dipped a toe into the US investment scene with the appointment of a New York investment banker as strategic advisor. [ + ]

Australian Cancer Technology (AustCancer) has changed tack with new management, a new product line and a move from Perth to Sydney -- all in one day. [ + ]

This year's Eureka prizes were awarded last night in their usual black and red finery at a dinner function at Fox studios in Sydney. [ + ]

An herbal remedy derived from the mukul myrrh tree and used in India to relieve heart symptoms actually raised cholesterol levels instead of lowering them as advertised, researchers said. [ + ]

Intel, chip maker to millions of personal computers across the world, is looking hard at the next emerging market -- biotech devices. [ + ]

It's one thing to design a system that can allow a library of 100,000 compounds to be screened against a protein structure in a day to assess each compound's structural compatibility with the target site. It's another to offer a way to score or rank the compounds according to the best-predicted fit. [ + ]

Melbourne drug delivery company Acrux has successfully completed a Phase I clinical study for its proprietary buspirone metered-dose transdermal spray (MDTS) for the treatment of anxiety. [ + ]

Brain and mind disorders, watch out -- Australia's neuroscience researchers are coming after you. [ + ]

A commercial alliance has been formed between the National Neuroscience Facility (NNF) and UK company Danio Labs, to develop a zebrafish model for Motor Neurone Disease (MND) and other neurodegenerative diseases. [ + ]

An Italian-Australian research partnership has demonstrated a potentially revolutionary technique for producing transgenic animals, using nature's own time-tested vector for delivering genes to eggs: sperm. [ + ]

Melbourne biotech Eiffel Technologies has signed an agreement with a UK-based drug delivery company, Meridica, to reengineer asthma therapeutics for use in a new technology inhalation device. [ + ]

EvoGenix has signed an agreement with UK-based Domantis to apply its protein evolution and optimisation technology to one of Domantis's domain antibody therapeutic leads. [ + ]

The Charles Sturt University (CSU) botanist who discovered the secret bushfire survival skills of the eucalypt has turned his attention to a suspected 'design flaw' in the endangered Wollemi Pine.